Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed strong safety and efficacy, with plans for a phase 2 trial in 2025.
‘The injection uses messenger RNA (mRNA) to instruct heart cells to produce #relaxin, a hormone that promotes blood vessel growth and improves blood flow. #hearthealth #medindia ’ The drug is ...
Riboswitches are RNA sensors that allow bacteria to sense and respond to their environment. Here, Bushhouse et al. demonstrate that the sensitivity of several riboswitches can be tuned by ...